Integrated platforms for immunotherapy research and biomarker analysis

Immunotherapy has transformed cancer treatment but 60-70% of patients still fail to respond to these treatments. The challenge lies in accurately identifying which patients will benefit from these therapies due to inadequate predictive biomarkers. However, the solution to this extends far beyond simply identifying more biomarkers.

Addressing existing challenges requires integrated platforms that maintain analytical depth while providing the standardization, throughput, and regulatory compliance needed for clinical implementation. Standard Biotools has developed advanced immune profiling technologies that simultaneously capture functional states, rare cell populations, and spatial relationships to help identify predictive biomarkers for immunotherapy response.

Download this SelectScience guide to explore how to:

• Reveal hidden biomarkers via functional immune profiling
• Scale discovery to clinical reality
• Capture spatial context and dynamic range
• Integrate transcriptomics and proteomics

Resource details:

• Document type: SelectScience guide
• Page count: 40
• Read time: 60 mins
• Edition: 1st